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Abstract Children with end-stage renal disease (ESRD)
have rates of mortality estimated to be 30-times higher than
expected for age compared with those of healthy children.
Physical manifestations of under-nutrition, such as body
mass index (BMI) and low height standard deviation score
(SDS), have been associated with increased risk of mortality.
Traditional measures, such as height, weight and serum
albumin concentration, may not be accurate indicators to
assess the nutritional status of children receiving mainte-
nance hemodialysis. Normalized protein catabolic rate
(nPCR) has emerged as a better marker of nutritional status
of such children. Meeting the special nutritional needs of
these children often requires nutritional supplementation, by
either theenteralortheparenteral route.Recently,in children
receiving maintenance hemodialysis who are malnourished,
intradialytic parenteral nutrition (IDPN) has been utilized
as a means to provide additional protein and calories. This
article is a state-of-the-art review of malnutrition in children
receiving maintenance hemodialysis, with special focus on






Malnutrition is a complex concept that is difficult to define. The
World Health Organization defines malnutrition as the “term
used to refer to a number of diseases, each with a specific cause
related to one or more nutrients and each characterized by
cellular imbalances between supply of nutrients and energy on
one hand and the body’s demand for them to ensure growth,
maintenance and specific functions on the other hand.” [1, 2].
Inadequate nutrient intake has traditionally been thought to be
the most important single cause of malnutrition in patients
receiving maintenance hemodialysis (HD) [3]. However, since
provision of nutrients alone does not correct this state, Mitch
and others have questioned the use of this term for patients
with end-stage renal disease (ESRD) that are receiving
maintenance dialysis [4–7]. They propose the term ‘cachexia’
to define the nutritional state in ESRD, with factors such as
metabolic acidosis and inflammation causing muscle wasting
and protein catabolism by involvement of the ubiquitin–
proteosome pathway.
Malnutrition [defined either by body mass index (BMI)
or biochemical markers such as albumin] is a well-
recognized complication and an independent risk factor
for increased mortality in adults with ESRD receiving
maintenance HD [8, 9]. Children with ESRD have rates of
mortality approximately 30-times higher than expected for
age when compared with those of healthy children [10, 11].
Although multiple factors might be responsible, physical
manifestations of malnutrition, such as short stature, lower
BMI, in the pediatric population have been demonstrated to
be associated with increased risk of death.
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not been standardized, determination of the exact preva-
lence of malnutrition in children receiving hemodialysis is
difficult. Height standard deviation score (SDS) and weight
SDS, available from the North American Pediatric Renal
Transplant Cooperative Study (NAPRTCS) 2006 annual
data, reveal mean height standard deviation score at
initiation of hemodialysis to be −1.50, declining to −1.93
after 24 months, and weight SDS to be −1.00 at initiation,
declining to −1.55 after 24 months [12], though low height
SDS can be due to reasons other than poor nutrition (see
Table 1).
Outcome Few large-scale studies have assessed the impact
of malnutrition on long-term outcomes in children receiving
long-term dialysis. Wong et al. [13] investigated the
association between height, weight, growth velocity, BMI
and mortality in 1,949 children with ESRD, including those
receiving HD, peritoneal dialysis or with a kidney trans-
plant. Their 7-year review of the US Renal Data System
database documented each decrease in height SDS of 1,
increased adjusted mortality risk (aRR) by 14% (aRR, 0.88,
95% CI 0.79 to 0.98). In addition, each decrease in growth
velocity of 1 SDS increased mortality risk by 12% (aRR
0.89, CI 0.80 to 1.00). The association between height
SDS, growth velocity SDS and mortality held true across
all ages and was independent of ESRD treatment modality.
Subsequently, Furth et al. [14], in a separate study,
demonstrated increased risk of death (RR 2.9, 95% CI
1.6, 5.3) in children with severe growth failure (≤3 SDS)
when compared with children with normal growth.
Multivariate analysis of body mass index SDS in the
study by Wong et al. [13] showed a U-shaped association
between BMI and risk of death, with extremes in BMI
associated with increased risk of death (Fig. 1). The finding
of an increased risk of death with a higher BMI in
children with ESRD is in contrast to the findings in
adults, where increased weight actually improves outcome
(Fig. 2). [15]. In fact, some of the traditional protective
factors contributing to decreased cardiovascular mortality
in the general population, such as low cholesterol level
and decreased weight, seem to have a negative influence
(reverse epidemiology) on mortality in adults with ESRD
[16].
In a separate pediatric study, Wong et al. [17] explored a
potential association of serum albumin and mortality over a
3-year follow-up period in 1,723 children with ESRD.
There were 93 deaths in 2,953 patient–years of observation.
Multivariate analysis revealed that patients with serum
albumin <3.5 g/dl exhibited a 90% greater risk of death
than patients with serum albumin >3.5 (aRR 1.9; 95% CI,
1.16 to 3.10). In addition, age, ESRD treatment modality
(transplant patients with lower mortality than those under-
going either hemodialysis or peritoneal dialysis) and height
SDS were also independently associated with mortality.
Though these studies demonstrated that low height SDS
and serum albumin levels are independent risk factors for
mortality, both variables may be influenced by several
factors other than nutrition status and do not provide
mechanistic insight into the associations observed. Pertur-
bation of growth hormone/insulin-like growth factor/growth
plate chondrocyte axis in pediatric ESRD is well known
and causes growth retardation. The studies by Wong et al.
[13] and Furth et al. [14] do not include data on growth
hormone use in this group of children, and since growth
hormone can increase height SDS in children with ESRD, it
can alter the height SDS variable, independent of nutritional
status. Serum albumin is not only influenced by nutrition
status but also by fluid status and inflammation [18, 19].
Kaysen et al. [19] demonstrated in 64 hemodialysis patients
enrolled in the hemodialysis (HEMO) study that inflamma-
tion caused increased fractional catabolic rate of serum
albumin, causing low levels independent of nutritional
variables. Jones and colleagues investigated the effect of
Table 1 Nutritional assessment parameters and their limitations (DEXA dual-energy X-ray absorptiometry)
Parameter Limitation
Weight False elevation due to fluid overload
Height Influenced by alterations of growth hormone axis, delayed puberty, renal osteodystrophy, independent of
nutritional state
MAC and triceps Can be influenced by altered regional distribution of fat/muscle
Skin fold thickness
Bio-impedance Unpredictable effect on estimation of fat-free mass from total body water in renal failure
Albumin/pre-albumin Albumin level associated with outcome, but levels influenced by inflammation and fluid overload; also limited
by long half-life. Pre-albumin shorter half-life but influenced by inflammation and fluid overload
Bone density (DEXA) Fluid overload can cause overestimation of lean mass
Normalized protein catabolic
rate (nPCR)
Only few studies available but emerging as nutrition marker for children receiving HD
MAC mid arm circumference
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ysis and showed that serum albumin level was indepen-
dently associated with extra-cellular fluid status [18].
Goldstein and co-workers [20] and Orellana and colleagues
[21] found that serum albumin was a poor marker of
nutritional status in children with severe malnutrition that
were receiving HD and who were being given intradialytic
parenteral nutrition (IDPN).
Nutrition assessment For the monitoring of nutritional
status of children on maintenance hemodialysis, the Kidney
Disease Outcomes Quality Initiative (K-DOQI) recom-
mends the following measures: dietary interview, serum
albumin, height or length, estimated dry weight, mid-arm
circumference, skin fold thickness, head circumference for
children aged 3 years or less, and SDS or Z scores [22]. The
pediatric renal dietician is invaluable to assess and manage
malnutrition in children with renal disease, and detailed
guidelines exist with regard to frequency of nutrition
assessment of children on maintenance hemodialysis [23].
However, the above parameters have their limitations [24],
as highlighted in Table 1.
The role of normalized protein catabolic rate (nPCR) in
the monitoring of the nutritional status of children receiving
long-term hemodialysis has been studied recently. Protein
catabolic rate (PCR) is a quantitative measure of protein
catabolism and can be calculated from nitrogen mass
balance studies with measurement of nitrogen excretion in
dialysate, urine and feces. However, this is cumbersome
and impractical in clinical settings. Borah et al. [25]
obtained urea generation rate and PCR (by nitrogen balance
studies) separately, and, by the use of regression estimates,
elegantly demonstrated the relationship between urea
generation rate and protein catabolic rate in five patients
receiving long-term HD, paving way for the derivation
of PCR from the interdialytic rise in urea generation
rate. The urea generation rate can be derived either by
formal urea kinetic modeling (UKM) or by an algebraic
equation [26]. The latter method has been shown to have
Fig. 2 Odds ratio of death among 12,965 adult patients grouped by
weight-for-height percentiles. Three representations are given in a
cluster of three bars. Black bars represent unadjusted odds ratio, white
bars represent odds ratio adjusted for clinical variables (age, gender,
race and diabetes mellitus), gray bars, adjusted for clinical and
laboratory variables (pre-dialysis serum albumin, creatinine and
cholesterol values). NS not significant. Reprinted with permission
from Macmillan Publishers Ltd., Kidney Int 56:1136–1148 [15]. The
P values symbols over a bar indicate the significant difference
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Fig. 1 The relative risk of death
and confidence intervals for
BMI standard deviation scores
among children with ESRD. The
minimum relative risk of death
is observed at a BMI=−0.50
SDS. The U-shaped association
was statistically significant;
P=0.001. Note that the lines for
all age strata and those of the
6 to 14 year age groups overlap.
(Used with permission from C.
Wong)
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generation rate (estG) is derived from the difference
between the post-treatment blood urea nitrogen (BUN)
(C1, expressed in milligrams per deciliter) and pretreat-
ment BUN (C2):
estG mg=min ðÞ ¼ C2   V2 ½    C1   V1 ½  ðÞ =T
where V1 is post-dialysis total body water (in deciliters;
V1=5.8 dl/kg × post-dialysis weight in kilograms), V2 is
predialysis total body water [in deciliters; V2=5.8 dl/kg ×
predialysis weight in kilograms], and T is time in minutes
from the end of dialysis treatment to the beginning of the
next treatment. Then, estimated nPCR can be calculated
from the modified equation of Borah et al. [25]:
nPCR ¼ 5:43   G=Vd þ 0:17
where Vd represents total body water after dialysis (0.58 ×
weight in kilograms). We recommend that nPCR be
measured monthly, together with Kt/V in dialysis units
where Kt/V is assessed.
Cano et al. [27], in an observational study, found
significant positive correlation between Kt/V vs daily
protein intake (DPI), protein catabolic rate (calculated from
measuring nitrogen losses in urine and dialysate) and
normalized protein nitrogen appearance (which they de-
rived from urea generation rate) but failed to observe
correlation between Kt/V and nitrogen balance in 20
children undergoing long-term peritoneal dialysis. The
absence of a relationship between dialysis dose and
nitrogen balance suggested that the correlation observed
between dialysis dose and protein catabolic rate resulted
from a mathematical tautology; however, DPI in their
patient population correlated with PCR (r=0.9), suggesting
that PCR was, in fact, reflective of nutritional status. Grupe
and colleagues [28] and Harmon and co-workers [29]
showed the correlation of nPCR to dietary protein intake
about 20 years ago and demonstrated that, without an
increase in dialysis dose, a moderate protein intake resulted
in a positive nitrogen balance. Recently, three pediatric
studies [20, 21, 30] have shown nPCR as a better marker
than albumin of subsequent weight loss in children on long-
term hemodialysis. Patients in the studies received adequate
dialysis (single pool Kt/V of 1.3); however, nPCR varied
with nutritional status. An nPCR<1 g/kg per day was
associated with weight and BMI- for-age loss in the
subsequent month, whereas nPCR>1 g/kg per day was
associated with progressive increases in both parameters
[30]. The relationship of nPCR to Kt/V might be interpreted
to reflect the increased dose of dialysis necessary to control
the urea of patients ingesting larger quantities of protein
[31]. However, nutrition analysis from the HEMO study in
adults demonstrated that the increasing of the dialysis dose
beyond the standard dose or the use of high-flux dialysis
did not improve albumin level or post-dialysis weight [32].
Marsenic et al. [33] showed, in 17 pediatric patients, that
Kt/V≤1.3 was associated with low nPCR (1.01±0.12 g/kg
per day) and Kt/V>1.3 with higher nPCR (1.27 to 1.33).
Yet, increasing dialysis dose (Kt/V) beyond 1.6 did not
have any further effect on nPCR. Tom and colleagues [34]
employed an intensive program in which 12 children
received an average of 155.9% of their recommended
protein intake and aggressive urea clearance (Kt/V>1.8)
and showed increased height SDS in ten of their children.
They concluded that aggressive nutritional support and
enhanced dialysis delivery lead to improved growth. In two
pediatric studies [20, 21], patients’ nutrition status as
measured by nPCR increased (monthly mean 1.07 to
1.38) with IDPN, with no change in their dialysis dose
(monthly mean of sp Kt/V 1.36 to 1.26). Studies of adults
have shown that daily HD or nocturnal HD can improve
appetite and food intake. This could contribute to increased
sense of well being, fewer dietetic restrictions and de-
creased use of medications such as phosphate binders and
sodium polystyrene sulfonate, drugs known to cause poor
appetite. In a pilot pediatric study, Fischbach et al. [35]
showed that hemodialysis five to six times a week led to
increased growth velocity in five pediatric patients. The
underlying mechanism for improved growth may not be
attributed solely to increment of the dialysis dose, since the
patients also received online hemodiafiltration with ultra-
pure dialysate, which could limit inflammation. Moreover,
dietary restrictions were removed for these children,
allowing them to have a high protein intake of 2 g/kg to
2.5 g/kg. Thus, we suggest that increasing dialysis dose
without addressing nutritional needs may not result in
improved growth.
Nutrition provision Recommended dietary allowance
(RDA) is the daily dietary intake level of a nutrient
considered sufficient to meet the requirements of nearly
all (97–98%) healthy individuals in each life stage and
gender group. The K-DOQI pediatric guidelines [22]
recommend caloric requirement to meet the RDA for age,
and initial dietary protein intake to meet RDA for
chronological age and an additional increment of 0.4/g/kg
per day to be provided to children receiving HD. This
recommendation is based on studies of adults that docu-
mented protein losses in fasting patients, during high-flux
hemodialysis, of approximately 8 g during a routine session
[36] and for whom the ingestion of 1.1 g/kg per day of
protein was not adequate to maintain nitrogen balance [37].
While it is clear that provision of nutritional supplement
is the most important factor in treating malnutrition in
infants and young children, this may not be true in older
children. In fact, whether nutritional supplements benefit
954 Pediatr Nephrol (2009) 24:951–957children over 2 years of age has been questioned [38].
Five studies addressed nutritional supplementation in
older children with chronic kidney disease out of which
two showed improvement in growth. However, none of
these studies were primarily of children receiving HD
[39–43]. Two pediatric studies suggested that increased
caloric and protein intake in addition to optimal dialysis is
needed to improve nutritional status (either growth or
weight gain) in older children receiving HD [20, 34].
Meeting the special nutritional needs for these children
requires nutritional supplement in the form of high
calorie formulas by oral or tube feeding/G-tube feedings.
Though the benefits of tube feeding for young children
and infants are clear, there are no studies available that
evaluate the success of this intervention in older children
and adolescents receiving hemodialysis. In a systematic
review of 28 studies of adults receiving hemodialysis,
enteral nutritional supplements, either as oral or tube
feeds, were shown to increase serum albumin by 2.3 g/l
[44].
Intradialytic parenteral nutrition (IDPN) has the advan-
tage of providing proteins and calories during HD without
the need for a separate central venous catheter. The
carbohydrate content prevents protein catabolism rather
than meeting caloric needs. Numerous studies of adults
have demonstrated the efficacy of this method [45, 46]i n
improving whole-body protein synthesis and a significant
decrease in whole-body proteolysis whereby there is net
change from an essentially catabolic state to positive
protein balance. A few studies have looked at the
effectiveness of IDPN in children. An early study showed
no improvement in amino acid levels after supplementation
with a low dose of amino acid (0.25 gm/kg) during dialysis
[47]. Goldstein et al. [20] highlighted the effectiveness of
IDPN by demonstrating reversal of weight loss and
initiation of weight gain within 6 weeks of starting IDPN
in three adolescent patients who had undergone ≥10%
weight loss over a 3-month period. In that study 40% of
weekly-prescribed protein intake was provided by IDPN
( 1 . 3g m / k gp e rt r e a t m e n t ) .I nas u b s e q u e n ts t u d yb y
Orellana et al. [21], IDPN was instituted for all adolescent
patients who had lost 10% body weight over a 3-month
period and were at <90% of their ideal body weight,
irrespective of the presence or absence of gastrointestinal
illness. The seven patients with organic illness gained
weight or BMI during the first 5 months of IDPN therapy,
whereas two patients with psychosocial-associated malnu-
trition did not [21], as shown in Table 2. The patients with
psychosocial malnutrition might not have improved their
enteral intake secondary to depression or might have had
inadequate access to food after IDPN initiation, resulting in
their lack of anthropometric improvement. We recommend
IDPN be used for patients who have been losing weight of
>10% for 3 consecutive months and who are less than 90%
of their ideal body weight and do not respond to enteral
supplementation.
In conclusion, optimizing maintenance hemodialysis in
children not only rests ensuring adequate dialysis dose but
also on the provision of adequate nutrition. Because of the
multifactorial pathogenesis of malnutrition, a multidisci-
plinary effort that includes nutritional, pharmacological and
metabolic interventions is required to prevent malnutrition.
Recent studies in children have focused on such interven-
tions and have added to our understanding to adequately
evaluate, prevent and treat malnutrition in children with
ESRD receiving maintenance hemodialysis.
Questions
(Answers appear following the reference list)
1. The anthropometric risk factors associated with
increased mortality in children with ESRD are all the
following except
a. Height SDS
b. Extremes of BMI
c. Growth velocity SDS
d. Weight SDS
2. Serum albumin as marker of nutritional status in
children has the following limitations except
a. Long half-life
b. Decrease in albumin level correlates with mortality
c. Decreases with inflammation
d. Decreases with fluid overload
3. All the following statements are true about nPCR except
a. Is a mathematical formula obtained from formal
urea kinetic modeling
b. Is estimated from urea generation rate
c. Has recently emerged in children with ESRD
receiving chronic hemodialysis as a marker of
protein intake
Table 2 IDPN and effect on BMI (patients 1 and 4 had psychosocial
malnutrition, whereas, for the remaining patients, the causes were
organic)
Patient Duration (months) BMI before IDPN BMI after IDPN
1 14 17.3 15.1
2 8 21.7 23.4
3 16 20.3 22.4
4 12 19.2 17.3
5 22 20.1 22.7
6 5 17.2 20.4
7 11 19.2 20.8
8 3 17.5 17.7
9 5 15.3 16.2
Pediatr Nephrol (2009) 24:951–957 955d. Was shown to be inferior to serum albumin as a
marker of subsequent weight loss in recent studies
4. Intradialytic parenteral nutrition (IDPN) has all the
following advantages except
a. Serves primarily as a protein source to patients
receiving chronic hemodialysis
b. Provides nutrition during hemodialysis without
the need for a separate central venous catheter
c. Reverses weight loss in all causes of protein
energy malnutrition (PEM)
d. Carbohydrate content prevents catabolism rather
than meeting caloric needs
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